Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 346 AL 360

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials

Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, Cassetta E, Woodward M, Boada M, van Dyck CH, Grimmer T, Selkoe DJ, Schneider A, Blondeau K, Hu N, Quartino A, Clayton D, Dolton M, Dang Y, Ostaszewski B, Sanabria-Bohórquez SM, Rabbia M, Toth B, Eichenlaub U, Smith J, Honigberg LA, Doody RS.

JAMA Neurol. 2022 Nov 1;79(11):1113-1121. doi: 10.1001/jamaneurol.2022.2909.

Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Qin M, Wu J, Zhou Q, Liang Z, Su Y.

J Psychiatr Res. 2022 Nov;155:371-379. doi: 10.1016/j.jpsychires.2022.09.039. Epub 2022 Sep 25.

Efficacy of methylphenidate for the treatment of apathy in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled studies

Lee CW, Chen JY, Ko CC, Chuang MH, Tsai WW, Sun CK, Hung KC.

Psychopharmacology (Berl). 2022 Dec;239(12):3743-3753. doi: 10.1007/s00213-022-06261-y. Epub 2022 Oct 15.

Role of caregivers on medication adherence management in polymedicated patients with Alzheimer's disease or other types of dementia

Muñoz-Contreras MC, Segarra I, López-Román FJ, Galera RN, Cerdá B.

Front Public Health. 2022 Oct 24;10:987936. doi: 10.3389/fpubh.2022.987936. eCollection 2022.

Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease

Gregory S, Saunders S, Ritchie CW.

Lancet Healthy Longev. 2022 Nov;3(11):e797-e803. doi: 10.1016/S2666-7568(22)00219-7.

The role of tonifying kidney decoction and acupuncture in the treatment of Alzheimer's disease: A network meta-analysis

Wang XC, Chu CL, Lu K, Chen X, Jin XQ, Quan SJ.

Medicine (Baltimore). 2022 Nov 18;101(46):e31243. doi: 10.1097/MD.0000000000031243.

Pharmacotherapy Evolution in Alzheimer's Disease: Current Framework and Relevant Directions

Miculas DC, Negru PA, Bungau SG, Behl T, Hassan SSU, Tit DM.

Cells. 2022 Dec 28;12(1):131. doi: 10.3390/cells12010131.

Aβ-Targeting Bifunctional Chelators (BFCs) for Potential Therapeutic and PET Imaging Applications

Krasnovskaya O, Kononova A, Erofeev A, Gorelkin P, Majouga A, Beloglazkina E.

Int J Mol Sci. 2022 Dec 23;24(1):236. doi: 10.3390/ijms24010236.

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual

Schwarz CG, Knopman DS, Ramanan VK, Lowe VJ, Wiste HJ, Cogswell PM, Utianski RL, Senjem ML, Gunter JR, Vemuri P, Petersen RC, Jack CR.

J Alzheimers Dis. 2022;85(1):59-64. doi: 10.3233/JAD-215052.

Mechanistic insight into the role of metformin in Alzheimer's disease

Sanati M, Aminyavari S, Afshari AR, Sahebkar A.

Life Sci. 2022 Feb 15;291:120299. doi: 10.1016/j.lfs.2021.120299. Epub 2022 Jan 7.

Psychotherapeutic interventions in individuals at risk for Alzheimer's dementia: a systematic review

Rostamzadeh A, Kahlert A, Kalthegener F, Jessen F.

Alzheimers Res Ther. 2022 Jan 31;14(1):18. doi: 10.1186/s13195-021-00956-8.

Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance

Nehra G, Bauer B, Hartz AMS.

Pharmacol Ther. 2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30.

Role of melatonin in Alzheimer's disease: From preclinical studies to novel melatonin-based therapies

Roy J, Wong KY, Aquili L, Uddin MS, Heng BC, Tipoe GL, Wong KH, Fung ML, Lim LW.

Front Neuroendocrinol. 2022 Apr;65:100986. doi: 10.1016/j.yfrne.2022.100986. Epub 2022 Feb 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias